Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery
1 other identifier
interventional
70
1 country
1
Brief Summary
This randomized, controlled, double-blind clinical trial aims to investigate the effectiveness of preoperative inspiratory muscle training (IMT) and expiratory muscle training (EMT) in patients scheduled for lung cancer surgery. Respiratory muscle dysfunction contributes to postoperative pulmonary complications (PPCs), prolonged hospitalization, and reduced functional recovery. Although IMT has been evaluated in several studies, the evidence is limited and heterogeneous, and the effectiveness of EMT in this population has never been studied. This study will compare conventional preoperative physiotherapy alone with physiotherapy combined with IMT or EMT to determine their impact on postoperative clinical outcomes, respiratory muscle function, and exercise capacity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable lung-cancer
Started Dec 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2025
CompletedFirst Posted
Study publicly available on registry
March 30, 2026
CompletedStudy Start
First participant enrolled
December 30, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
Study Completion
Last participant's last visit for all outcomes
December 30, 2026
March 30, 2026
March 1, 2026
Same day
November 27, 2025
March 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative Pulmonary Complications (PPCs)
Presence of postoperative pulmonary complications assessed using the Melbourne Group Scale (8 diagnostic criteria including fever, leukocytosis, radiological infiltrates, oxygen desaturation, increased secretions, abnormal lung auscultation, respiratory deterioration, and evidence of infection). A PPC is recorded if ≥4 criteria are met.
Average 2 weeks.
Secondary Outcomes (8)
Length of Hospital Stay
Average 2 weeks.
Maximum Inspiratory Pressure (MIP)
Baseline and preoperative reassessment.
Maximum Expiratory Pressure (MEP)
Baseline and preoperative reassessment.
Six-Minute Walk Distance (6MWD)
Baseline and preoperative reassessment.
Forced Expiratory Volume in 1 Second (FEV₁)
Baseline and preoperative reassessment.
- +3 more secondary outcomes
Study Arms (3)
Inspiratory Muscle Training + Conventional Physiotherapy
EXPERIMENTALParticipants receive the full conventional physiotherapy program plus Inspiratory Muscle Training (IMT) using a threshold device set initially at 40% of the individual's maximum inspiratory pressure (MIP). Training consists of 2 minutes of loading followed by 1 minute of rest, repeated 7 times (total 21 minutes), performed twice daily, 5 days per week, until surgery.
Expiratory Muscle Training + Conventional Physiotherapy
EXPERIMENTALParticipants receive the full conventional physiotherapy program plus Expiratory Muscle Training (EMT) using a threshold-based expiratory device set at 40% of maximum expiratory pressure (MEP). Training follows the same schedule as the IMT protocol (2 min loading / 1 min rest × 7 cycles), twice daily, 5 days per week, until surgery.
Conventional Preoperative Physiotherapy (Control Group)
EXPERIMENTALParticipants receive the standard preoperative physiotherapy program including diaphragmatic and thoracic breathing exercises, basal breathing techniques, and individualized walking training based on 80% of the 6-minute walk test distance. Three supervised sessions (one in-person, two via videoconference) are followed by daily home exercises until the surgery date. No respiratory muscle training device is used.
Interventions
Inspiratory muscle training is performed using a threshold device (PowerBreathe Classic) beginning at 40% of the individual's maximum inspiratory pressure (MIP). Training consists of 2 minutes of loading followed by 1 minute of rest, repeated for 7 cycles (total 21 minutes), performed twice daily, 5 days per week, until surgery. Load progression is adjusted to maintain a Borg dyspnea score of approximately 4/10. IMT is provided in addition to the full conventional physiotherapy program.
Expiratory muscle training is performed using a threshold expiratory device (PowerBreathe Expir Medic) starting at 40% of the individual's maximum expiratory pressure (MEP). The protocol follows the same structure as IMT: 2 minutes loading / 1 minute rest for 7 cycles (21 minutes), twice daily, 5 days per week, until surgery, with load progression based on a Borg score of 4/10. EMT is provided in addition to the full conventional physiotherapy program.
The conventional physiotherapy program includes diaphragmatic, basal, and thoracic breathing exercises, pursed-lip breathing, and walking training prescribed at 80% of the distance achieved during the six-minute walk test. Participants receive one in-person supervised session followed by two videoconference reinforcement sessions and then continue daily home exercises until the day of surgery.
Eligibility Criteria
You may qualify if:
- Diagnosis of lung cancer staged IA to IIIB based on clinical staging
- Planned to undergo surgery via thoracotomy or videothoracoscopy (VATS)
- Having a smartphone and being capable of performing video call
You may not qualify if:
- Presence of a cardiac disease that affects quality of life (ASA II or better is required)
- Presence of severe cognitive problems or psychiatric disorders
- Presence of physical limitations (e.g., visual or hearing impairment, orthopedic problems)
- If the lung cancer diagnosis is not confirmed after frozen section or wedge resection, the patient will be removed from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saglik Bilimleri Universitesi
Istanbul, Üsküdar, 34668, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- This study uses a double-blind design. Participants are blinded to group allocation, as all groups receive a physiotherapy program and a handheld respiratory device that appears similar in structure. The outcome assessors conducting pre- and postoperative evaluations (spirometry, respiratory muscle strength, 6MWT, and postoperative complication assessment) are also blinded to group assignment. Treating physiotherapists delivering the IMT/EMT interventions are not blinded due to the nature of the training protocols; however, they are not involved in outcome assessment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 27, 2025
First Posted
March 30, 2026
Study Start (Estimated)
December 30, 2026
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
March 30, 2026
Record last verified: 2026-03